On the other hand, IL-6, iNOS, TNFα, CD36, CD16, and CD169 were modulated significantly only in T2DM, suggesting that chronic hyperglycemia could be the modulator of these markers. This evidence concerns the gene SIGLEC1 and type 2 diabetes mellitus.